CA2367658A1 - Method for treatment of reactive arthritis or bursitis - Google Patents

Method for treatment of reactive arthritis or bursitis Download PDF

Info

Publication number
CA2367658A1
CA2367658A1 CA002367658A CA2367658A CA2367658A1 CA 2367658 A1 CA2367658 A1 CA 2367658A1 CA 002367658 A CA002367658 A CA 002367658A CA 2367658 A CA2367658 A CA 2367658A CA 2367658 A1 CA2367658 A1 CA 2367658A1
Authority
CA
Canada
Prior art keywords
bursitis
treatment
reactive arthritis
metronidazole
lysine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002367658A
Other languages
French (fr)
Other versions
CA2367658C (en
Inventor
Robert Hines
Ernest Bonner, Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ficaar Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2367658A1 publication Critical patent/CA2367658A1/en
Application granted granted Critical
Publication of CA2367658C publication Critical patent/CA2367658C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

An improved method is provided for treatment of conditions in human beings associated with either or both reactive arthritis or bursitis comprising administration of a combination of L-lysine, minocycline hydrochloride, isonicotinic acid hydrazide, and metronidazole.
CA002367658A 1999-03-17 2000-03-15 Method for treatment of reactive arthritis or bursitis Expired - Fee Related CA2367658C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/270,962 1999-03-17
US09/270,962 US6087382A (en) 1999-03-17 1999-03-17 Method for treatment of reactive arthritis or bursitis
PCT/US2000/007104 WO2000054781A1 (en) 1999-03-17 2000-03-15 Method for treatment of reactive arthritis or bursitis

Publications (2)

Publication Number Publication Date
CA2367658A1 true CA2367658A1 (en) 2000-09-21
CA2367658C CA2367658C (en) 2007-06-05

Family

ID=23033590

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002367658A Expired - Fee Related CA2367658C (en) 1999-03-17 2000-03-15 Method for treatment of reactive arthritis or bursitis

Country Status (4)

Country Link
US (2) US6087382A (en)
AU (1) AU3757000A (en)
CA (1) CA2367658C (en)
WO (1) WO2000054781A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756060B1 (en) * 1996-09-19 2004-06-29 Usbiomaterials Corp. Anti-inflammatory and antimicrobial uses for bioactive glass compositions
US6765000B2 (en) * 1999-03-17 2004-07-20 Bonner Jr Ernest L Treatment for reactive arthritis or bursitis
US6197776B1 (en) * 1999-03-17 2001-03-06 Ernest L. Bonner, Jr. Method for treatment of reactive arthritis or bursitis
US7884090B2 (en) * 1999-03-17 2011-02-08 Ernest L. Bonner, Jr. Compositions and methods for the treatment of arthritis
US7691831B2 (en) * 1999-03-17 2010-04-06 Ernest L. Bonner, Jr. Pharmaceutical combination and method for treatment of reactive arthritis or bursitis
US6087382A (en) * 1999-03-17 2000-07-11 Bonner, Jr.; Ernest L. Method for treatment of reactive arthritis or bursitis
US20050137181A1 (en) * 1999-03-17 2005-06-23 Bonner Ernest L. Method for treatment of reactive arthritis or bursitis
US20050154046A1 (en) * 2004-01-12 2005-07-14 Longgui Wang Methods of treating an inflammatory-related disease
US7582670B2 (en) * 2001-12-13 2009-09-01 Natrogen Therapeutics, Inc. Methods of treating an inflammatory-related disease
US8563525B2 (en) 2004-01-12 2013-10-22 Natrogen Therapeutics International, Inc. Methods of treating an inflammatory-related disease
US20040086581A1 (en) * 2002-11-06 2004-05-06 Jones Edwin B. Bio-energetic joint and arthritis pain formula
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US20080242642A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US9192615B2 (en) 2008-08-06 2015-11-24 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8747387B2 (en) * 2005-10-11 2014-06-10 Covidien Lp IV catheter with in-line valve and methods related thereto
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
CA2609104C (en) * 2007-04-10 2017-09-05 Exist Marketing Pty Ltd Method and device for treating bursitis
CN101426268B (en) * 2007-11-02 2010-08-25 大唐移动通信设备有限公司 Pilot resource distribution method, system and equipment
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2946801A (en) * 1957-06-05 1960-07-26 Standard Oil Co Production of pyridine carboxylic acids
US3148212A (en) * 1961-12-22 1964-09-08 American Cyanamid Co Reductive alkylation process
USRE26253E (en) * 1963-05-17 1967-08-15 And z-alkylamino-g-deoxytetracycline
US4177796A (en) * 1977-08-22 1979-12-11 Franco Vila Jose J Magnetic thermal vibrational device for the treatment of arthritis and the like
US4521411A (en) * 1983-11-04 1985-06-04 Theodora Koloff Analgesic composition
US5523297A (en) * 1993-03-02 1996-06-04 The Research Foundation Of State University Of New York Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
US5952367A (en) * 1997-04-25 1999-09-14 Pak; Kyoungsik Method of treating pain cause by bursitis tendinitis arthritis
US6087382A (en) * 1999-03-17 2000-07-11 Bonner, Jr.; Ernest L. Method for treatment of reactive arthritis or bursitis

Also Published As

Publication number Publication date
US6087382A (en) 2000-07-11
CA2367658C (en) 2007-06-05
US6465473B1 (en) 2002-10-15
AU3757000A (en) 2000-10-04
WO2000054781A1 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
CA2367658A1 (en) Method for treatment of reactive arthritis or bursitis
EP0978276A3 (en) Polymer coated tablet comprising amoxycillin and clavunalate
HUP9600924A2 (en) Aromatic hydroxamic acid derivatives, their production, use and pharmaceutical compn. contg. the said compds.
MY132490A (en) 2-aryl-substituted pyridines
CA2186260A1 (en) Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide
HK1047575A1 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containingthe same.
HUP9903405A3 (en) Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids with metalloproteinase inhibitor activity, preparation and use thereof
GB9822440D0 (en) Medicaments
AU3674500A (en) L-amino acid-producing bacteria and process for producing l-amino acid
AU6825300A (en) Compounds
WO2002003920A3 (en) Method for treatment of reactive arthritis or bursitis
WO2003051275A3 (en) Benzodiazepine derivatives, preparation thereof and use thereof
AU1661901A (en) Improved lactic acid processing; methods; arrangements; and, products
CA2241014A1 (en) Morphine derivatives with analgesic activity
AU2354095A (en) Process for inhibiting the growth of a culture of lactic acid bacteria, and optionally lysing the bacterial cells, and uses of the resulting lysed culture
AU3366899A (en) Novel hiv integrase inhibitors and hiv therapy based on drug combinations including integrase inhibitors
WO2004034987A3 (en) Treatment for reactive arthritis or bursitis
EP1745790A3 (en) Treatment of rumen acidosis with alpha-amylase inhibitors
AU3695297A (en) Alfa-amino acid amides, preparation thereof and the therapeutical use thereof
IE863186L (en) Fluoroallylamines
AU4969997A (en) Aqueous nutritive preparation comprising lactic acid, organic acid and chelated trace elements
AU2353995A (en) Process for the lysis of a culture of lactic acid bacteria by means of a lysin, and uses of the resulting lysed culture
AU2662799A (en) Modified pharmacologically active agents and improved therapeutic methods employing same
ZA200006081B (en) Novel octahydro-6, 10-dioxo-6h-pyridazino/1,2-A/ /1,2/diazepin-1-carboxylic acid derivatives, preparation method and use for preparing therapeutically active compounds.
HUT67089A (en) Acyl-oxy-hexanic acid derivatives and process for prepg. said compd. and pharmaceutical compn. contg. them

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed